Proteomics reveals protein phosphatase 1γ as a biomarker associated with Hippo signal pathway in glioma.

[1]  Jie Lin,et al.  Identification of Prognostic Signatures of Alternative Splicing in Glioma , 2020, Journal of Molecular Neuroscience.

[2]  Xiao-li Zhang,et al.  Functional significance of Hippo/YAP signaling for drug resistance in colorectal cancer , 2018, Molecular carcinogenesis.

[3]  J. Xi,et al.  Identification of COX5B as a novel biomarker in high-grade glioma patients , 2017, OncoTargets and therapy.

[4]  T. Komori,et al.  The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision , 2017, Neurologia medico-chirurgica.

[5]  Yuan Zhang,et al.  Quantitative proteomic analysis of gastric cancer tissue reveals novel proteins in platelet-derived growth factor B signaling pathway , 2017, Oncotarget.

[6]  Yang Jiang,et al.  Expression and significance of Hippo/YAP signaling in glioma progression , 2016, Tumor Biology.

[7]  Stefano Piccolo,et al.  YAP/TAZ at the Roots of Cancer. , 2016, Cancer cell.

[8]  B. Mao,et al.  Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance , 2016, Chinese journal of cancer.

[9]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[10]  Z. Bao,et al.  Protein phosphatase 1γ regulates the proliferation of human glioma via the NF-κB pathway. , 2016, Oncology reports.

[11]  Kai Wang,et al.  Circular RNA profile in gliomas revealed by identification tool UROBORUS , 2016, Nucleic acids research.

[12]  I. Mellinghoff,et al.  Molecular Pathways: Isocitrate Dehydrogenase Mutations in Cancer , 2016, Clinical Cancer Research.

[13]  Xiaolong Yang,et al.  The Hippo pathway in chemotherapeutic drug resistance , 2015, International journal of cancer.

[14]  T. Jiang,et al.  IDH mutation and MGMT promoter methylation in glioblastoma: results of a prospective registry , 2015, Oncotarget.

[15]  Zengliang Wang,et al.  Upregulation of miR-130b enhances stem cell-like phenotype in glioblastoma by inactivating the Hippo signaling pathway. , 2015, Biochemical and biophysical research communications.

[16]  Alexander R. Pico,et al.  Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. , 2015, The New England journal of medicine.

[17]  M. Moran,et al.  Comprehensive proteome analysis of fresh frozen and optimal cutting temperature (OCT) embedded primary non-small cell lung carcinoma by LC-MS/MS. , 2015, Methods.

[18]  Yonghua Liu,et al.  Expression of far upstream element (FUSE) binding protein 1 in human glioma is correlated with c‐Myc and cell proliferation , 2015, Molecular carcinogenesis.

[19]  J. Barnholtz-Sloan,et al.  The epidemiology of glioma in adults: a "state of the science" review. , 2014, Neuro-oncology.

[20]  P. LaViolette,et al.  Comprehensive characterization of glioblastoma tumor tissues for biomarker identification using mass spectrometry-based label-free quantitative proteomics. , 2014, Physiological genomics.

[21]  C. Liu,et al.  Suppression of KIF3B Expression Inhibits Human Hepatocellular Carcinoma Proliferation , 2013, Digestive Diseases and Sciences.

[22]  Guohui Wan,et al.  Protein phosphatase 1 inhibits p53 signaling by dephosphorylating and stabilizing Mdmx. , 2013, Cellular signalling.

[23]  David M. Thomas,et al.  The Hippo pathway and human cancer , 2013, Nature Reviews Cancer.

[24]  M. Mann,et al.  The coming age of complete, accurate, and ubiquitous proteomes. , 2013, Molecular cell.

[25]  K. Guan,et al.  The Hippo pathway: regulators and regulations. , 2013, Genes & development.

[26]  Chun Cheng,et al.  Numbl inhibits glioma cell migration and invasion by suppressing TRAF5-mediated NF-κB activation , 2012, Molecular biology of the cell.

[27]  Palaniappan Sethu,et al.  Clinical neuroproteomics and biomarkers: from basic research to clinical decision making. , 2012, Neurosurgery.

[28]  S. Ferguson.  Malignant gliomas: diagnosis and treatment. , 2011, Disease-a-month : DM.

[29]  P. Northcott,et al.  Oncogenic YAP promotes radioresistance and genomic instability in medulloblastoma through IGF2-mediated Akt activation , 2011, Oncogene.

[30]  C. Eberhart,et al.  Yes-Associated Protein 1 Is Widely Expressed in Human Brain Tumors and Promotes Glioblastoma Growth , 2011, Journal of neuropathology and experimental neurology.

[31]  Wilhelm Krek,et al.  URI is an oncogene amplified in ovarian cancer cells and is required for their survival. , 2011, Cancer cell.

[32]  B. Kuster,et al.  Proteomics: a pragmatic perspective , 2010, Nature Biotechnology.

[33]  S. Brunak,et al.  Quantitative Phosphoproteomics Reveals Widespread Full Phosphorylation Site Occupancy During Mitosis , 2010, Science Signaling.

[34]  M. Mann,et al.  Universal sample preparation method for proteome analysis , 2009, Nature Methods.

[35]  G. Feldmann,et al.  Elucidation of a Universal Size-Control Mechanism in Drosophila and Mammals , 2007, Cell.

[36]  Irene L Andrulis,et al.  The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors , 2007, BMC Cancer.

[37]  R. Sposto,et al.  A limited screen for protein interactions reveals new roles for protein phosphatase 1 in cell cycle control and apoptosis. , 2007, Journal of proteome research.

[38]  E. Villa-Moruzzi,et al.  Direct interaction between the catalytic subunit of Protein Phosphatase 1 and pRb , 2006, Cancer Cell International.

[39]  Michael Weller,et al.  Changing paradigms--an update on the multidisciplinary management of malignant glioma. , 2006, The oncologist.

[40]  D. Haber,et al.  salvador Promotes Both Cell Cycle Exit and Apoptosis in Drosophila and Is Mutated in Human Cancer Cell Lines , 2002, Cell.

[41]  S. Shenolikar,et al.  The Neuronal Actin-binding Proteins, Neurabin I and Neurabin II, Recruit Specific Isoforms of Protein Phosphatase-1 Catalytic Subunits* , 2002, The Journal of Biological Chemistry.

[42]  Patricia T W Cohen,et al.  Protein phosphatase 1--targeted in many directions. , 2002, Journal of cell science.

[43]  C. Wan,et al.  Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma , 2016, Digestive Diseases and Sciences.

[44]  M. Wilkins,et al.  Progress with gene‐product mapping of the Mollicutes: Mycoplasma genitalium , 1995, Electrophoresis.